Lucas Ward
Stock Analyst at Ascendiant
(0.03)
# 4,427
Out of 4,429 analysts
56
Total ratings
11.9%
Success rate
-53.3%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACON Aclarion | Maintained: Buy | $7 → $7.5 | $3.12 | +140.38% | 8 | May 28, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Maintained: Buy | $4.2 → $3.7 | $1.64 | +125.61% | 10 | May 22, 2026 | |
| LIQT LiqTech International | Maintained: Buy | $4.3 → $4.4 | $0.90 | +388.89% | 10 | May 20, 2026 | |
| VVOS Vivos Therapeutics | Reiterated: Buy | $5.5 → $3 | $0.50 | +500.00% | 11 | Apr 22, 2026 | |
| HSCS HeartSciences | Maintained: Buy | $9.2 → $8 | $1.84 | +334.78% | 12 | Mar 23, 2026 | |
| VMAR Vision Marine Technologies | Maintained: Buy | $30 → $10 | $2.97 | n/a | 5 | Apr 30, 2025 |
Aclarion
May 28, 2026
Maintained: Buy
Price Target: $7 → $7.5
Current: $3.12
Upside: +140.38%
60 Degrees Pharmaceuticals
May 22, 2026
Maintained: Buy
Price Target: $4.2 → $3.7
Current: $1.64
Upside: +125.61%
LiqTech International
May 20, 2026
Maintained: Buy
Price Target: $4.3 → $4.4
Current: $0.90
Upside: +388.89%
Vivos Therapeutics
Apr 22, 2026
Reiterated: Buy
Price Target: $5.5 → $3
Current: $0.50
Upside: +500.00%
HeartSciences
Mar 23, 2026
Maintained: Buy
Price Target: $9.2 → $8
Current: $1.84
Upside: +334.78%
Vision Marine Technologies
Apr 30, 2025
Maintained: Buy
Price Target: $30 → $10
Current: $2.97
Upside: n/a